AccelBio participated in BioEurope event in Munich from November 6th to 8th, actively advancing the frontiers of biotech. With a commitment to advancing the boundaries of biotech, AccelBio strategically utilized the event to explore synergies with industry leaders, investors, and potential partners.

At the conference, AccelBio unveiled its cutting-edge Organoids platform, presenting a pivotal opportunity to forge partnerships that will expedite the development and commercialization of groundbreaking medicines.

Subscribe
Sign up with your email address to receive news and updates.
Subscription Form

By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.
Latest news

Ideas Without Borders: The BIO-RED Cross-Regional Showcase

On November 4th, 2026, BIO-RED held its first Cross-Regional Showcase, “Ideas Without Borders”, an online event bringing together innovators, investors, […]
Read more

AccelBio at the Innovating Health Together Conference 2026

AccelBio took part in the Innovating Health Together Conference 2026 (IHTC’26), “Resilient and Sustainable Health Systems for the Future”, a […]
Read more

Ten Business Cases Selected for the BIO-RED Accelerator Programme

On October 26th, 2026, the BIO-RED Inter-Regional Final Pitch Session brought together the 14 regional finalists from across all the […]
Read more
1 2 3 … 19
Posted on
November 13, 2023
Author
Co-Lab AccelBio
Categories

Contact Us

geral@accelbio.pt+351 918 439 722
Call to national mobile network
Laboratório Colaborativo AccelBio
Biocant Park,
Parque Tecnológico de Cantanhede,
3060-197 Cantanhede
2026 Co-Lab AccelBio All rights reserved ©
|
Designed and built by BOTODACRUZ